Inc Research Holdings Stock Today
| INCR Stock | USD 1.49 0.06 3.87% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
INC Research is selling at 1.49 as of the 21st of March 2025; that is 3.87 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.48. INC Research has about a 41 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 7th of November 2014 | Category Healthcare | Classification Health Care |
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel. The company has 47.16 M outstanding shares of which 27.43 K shares are currently shorted by private and institutional investors with about 0.99 trading days to cover. More on INC Research Holdings
Moving against INC Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
INC Stock Highlights
| CEO Director | Alexander Rabinovich | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite Total, Tel Aviv 60, Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsINC Research can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand INC Research's financial leverage. It provides some insight into what part of INC Research's total assets is financed by creditors.
| |||||
INC Research Holdings (INCR) is traded on NASDAQ Exchange in USA. It is located in 85 Medinat ha-Yehudim Street, Herzliya, Israel, 4676670 and employs 270 people. INC Research is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 70.27 M. INC Research Holdings conducts business under Biotechnology sector and is part of Health Care industry. The entity has 47.16 M outstanding shares of which 27.43 K shares are currently shorted by private and institutional investors with about 0.99 trading days to cover.
INC Research Holdings currently holds about 305.06 M in cash with (53.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.92, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check INC Research Probability Of Bankruptcy
Ownership AllocationINC Research Holdings secures a total of 47.16 Million outstanding shares. INC Research shows substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check INC Ownership Details
INC Research Historical Income Statement
INC Stock Against Markets
INC Research Corporate Management
| Amos Cohen | Chief Officer | Profile | |
| Itai Kabiljo | General Counsel | Profile | |
| Advocate Ohayon | CoFounder Ltd | Profile | |
| Einat Zehavi | Vice Sales | Profile | |
| OriMoni Mimon | CoFounder Ltd | Profile |
Additional Tools for INC Stock Analysis
When running INC Research's price analysis, check to measure INC Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INC Research is operating at the current time. Most of INC Research's value examination focuses on studying past and present price action to predict the probability of INC Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INC Research's price. Additionally, you may evaluate how the addition of INC Research to your portfolios can decrease your overall portfolio volatility.